ⓘ Glaucoma medication

                                     

ⓘ Glaucoma medication

The goal of currently available glaucoma therapy is to preserve visual function by lowering intraocular pressure below a level that is likely to produce further damage to the nerve. The treatment regimen that achieves the goal of preserving function with the lowest risk, fewest adverse effects, and least disruption of the patients life, taking into account the cost implications of treatment, should be the approach taken.

The more advanced the glaucomatous process on initial presentation, the lower the target range generally essential to prevent further progression. This more aggressive goal are designed to minimize the risk of progressive glaucoma damage and vision loss. When the optic nerve is damaged, it is likely to incur more damage, and severe loss of vision is present, there is a greater impact on the patient from any additional damage that may occur.

The initial lowering of the intraocular pressure by 20% from the initial level proposed. However, reducing IOP to the target pressure range does not guarantee that progression will not occur. Thus, the target pressure range needs to be constantly reviewed and changes depending on fluctuations in IOP, changes in the optic nerve and / or visual field progression.